Navigation Links
UCLA, Caltech research on immune-cell therapy could strengthen promising melanoma treatment
Date:3/22/2013

A new study of genetically modified immune cells by scientists from UCLA and the California Institute of Technology could help improve a promising treatment for melanoma, an often fatal form of skin cancer.

The research, which appears March 21 in the advance online edition of the journal Cancer Discovery, was led by James Heath, a member of UCLA's Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research and UCLA's Jonsson Comprehensive Cancer Center. Heath is a professor of molecular and medical pharmacology at UCLA and also holds the Elizabeth W. Gilloon Chair in Chemistry at Caltech.

The melanoma treatment uses T cells immune cells that play a major role in fighting infection taken from patients with melanoma. The cells are then genetically modified in the laboratory so that when they are reintroduced into a patient's bloodstream, they specifically attack melanoma tumors. In early clinical trials, this treatment was shown to shrink tumors dramatically in many patients, but the positive effects were often short-lived.

The UCLA and Caltech researchers found that after the engineered T cells were returned to patients, their efficacy faded within two to three weeks. Surprisingly, however, once the engineered cells were no longer effective, a new group of non-engineered T cells arose that had a similar tumor-killing effect that lasted even longer, the scientists discovered.

Using newly developed nanotechnology chips to perform multidimensional and multiplexed immune-monitoring assays, the researchers were able to examine at high resolution single engineered T cells taken at different times from patients undergoing the therapy, each of whom had a different level of response to the treatment.

"The engineered T cells did not recover their tumor-killing effect," Heath said, "but after one month, another group of T cells appeared that did have tumor-killing effects for another 90 days. Th
'/>"/>

Contact: Shaun Mason
smason@mednet.ucla.edu
310-206-2805
University of California - Los Angeles
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Scientists from UCLA, Israels Technion uncover brains code for pronouncing vowels
2. Michigan Lupus Foundation Texas Hold 'Em Tournament Raises Thousands for Lupus Support, Education & Research
3. Frisco Institute for Reproductive Medicine Welcomes China Research Team
4. Research explores links between physical and emotional pain relief
5. Multiple sclerosis research: The thalamus moves into the spotlight
6. Dr. Roger D. Weiss earns Hazeldens Dan Anderson Research Award
7. Patient Wishes Should Guide End-of-Life Care, Researchers Say
8. Scripps Research study underlines potential of new technology to diagnose disease
9. Researchers new method may sharpen microscopic images
10. New web portal on health research in Europe
11. Researchers tackle physician challenge of correctly ordering laboratory tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 03, 2015 Retrofit , the ... America’s leading corporations, today announces the appointment of its ... positions. CEO Mary Pigatti has recruited technology, ... employee engagement for the fast-growing company, which was recently ... for 2015. , “Retrofit is thrilled to announce ...
(Date:3/3/2015)... March 3, 2015, My Positive Perspective host was joined ... a unique one, not just because it was the first ... men who were both faced with monumental obstacles after being ... episode, Deierlein said to Collins, “I had the opportunity to ... very excited that you could join me on the set ...
(Date:3/3/2015)... 03, 2015 eMedEvents, a searchable ... medical education (CME) credit information, has officially been ... was initially launched in the United States (December ... kind in the field of healthcare conference technology ... this Denver, Colorado-based start-up company was successful as ...
(Date:3/3/2015)... FAYETTEVILLE, Ark. (PRWEB) March 03, 2015 ... , announced that Mr. William A. Breukelman has been ... has recently completed development of the first fully integrated ... is uniquely capable of analyzing the three-dimensional motion of ... and then comparing the analysis at 15,300 points to ...
(Date:3/3/2015)... York, NY (PRWEB) March 03, 2015 Ticket ... tickets for her 2015 tour. This well-known ticket ... added savings. , Arguably the biggest name in the music ... when Madonna performs on the “Rebel Heart Tour.” Madonna, fresh ... month will kick off her latest tour on August 29th ...
Breaking Medicine News(10 mins):Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 2Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 3Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 4Health News:My Positive Perspective Releases Episode #200 With Car Accident and Coma Survivor Nick Collins 2Health News:eMedEvents Launches Online Medical Conference, Speaker and CME Platform in India 2Health News:William A. (Bill) Breukelman Named to CardioWise, Inc. Board of Directors 2Health News:William A. (Bill) Breukelman Named to CardioWise, Inc. Board of Directors 3Health News:Cheap Madonna Tickets: Madonna Presale Tickets in Miami, New York, Brooklyn, Chicago, San Jose, Toronto, Edmonton & Vancouver Now Available at TicketDown.com 2Health News:Cheap Madonna Tickets: Madonna Presale Tickets in Miami, New York, Brooklyn, Chicago, San Jose, Toronto, Edmonton & Vancouver Now Available at TicketDown.com 3
... more often in spinal fusions, but experts worry about costs ... A relatively new agent that stimulates the creation of new ... used in the United States, although costs and some complication ... new study reports. , The therapeutic agent, known as bone-morphogenic ...
... disease-linked factors don,t perform better than standard criteria, study ... biomarkers of cardiac risk, such as inflammation-linked C-reactive ... older, established factors such as smoking, obesity, high cholesterol ... newer blood-borne markers have been touted as a better ...
... decode the human genome and the information becomes publicly ... multiplying. Scientists at the National Institutes of Health were ... They evaluated responses to an online test among smokers ... variant associated with risk for lung cancer. The results, ...
... Study finds increased risk for postmenopausal women , ... blood pressure, elevated glucose and other components of metabolic ... cancer, a new study suggests. , Metabolic syndrome, also ... of such conditions as abdominal obesity, high blood glucose ...
... DALLAS, June 30 At the 8th Annual Spirit ... of North Texas (EFNT) recognized The Beryl Companies, the ... healthcare organizations, as the North Star 2009 Inductee. This ... example and show the importance of giving back to ...
... June 30 Every summer, the bloodsuckers send Canadians swatting ... good reason. , , More than just creatures ... and cause human flesh to swell and redden. An even ... , , While many Canadians warily use conventional ...
Cached Medicine News:Health News:Assessment of Bone Growth Stimulator Is Mixed 2Health News:Assessment of Bone Growth Stimulator Is Mixed 3Health News:Newer Blood Tests May Not Improve Heart Risk Assessment 2Health News:Newer Blood Tests May Not Improve Heart Risk Assessment 3Health News:Possible benefit from online genetic testing for lung cancer 2Health News:Metabolic Syndrome May Make Breast Cancer More Likely 2Health News:Beryl Receives Entrepreneurs Foundation of North Texas North Star Recognition 2
(Date:3/3/2015)... Today, the Partnership for Prescription Assistance ... research companies, unveiled a redesigned website ... and caregivers with faster, easier access to information ... assistance programs. Since its launch ... engage, educate and empower patients and caregivers to ...
(Date:3/3/2015)... BETHESDA, Md. , March 3, 2015 /PRNewswire/-- ViaCyte, ... stem cell-derived islet replacement therapy for the treatment of ... Dr. Eugene Brandon , Director of Strategic Relations ... annual summit showcases the latest in type 1 diabetes ... presentation are as follows: , , , ...
(Date:3/3/2015)... VIEW, Calif. , March 3, 2015 /PRNewswire/ ... enhanced drug discovery market, Frost & Sullivan recognizes ... & Sullivan Award for Technology Leadership. Neopeutics has ... clients a robust, cost-effective, and easily adaptable set ... agents that are catalogued as failing compounds in ...
Breaking Medicine Technology:Partnership for Prescription Assistance Relaunches Website with New Features for Patients and Caregivers 2ViaCyte to Present at JDRF TypeOneNation Research Summit 2Frost & Sullivan Applauds Neopeutics' Commitment to Accelerating the Delivery of New Nature-Based Pharmaceuticals and Therapeutics 2Frost & Sullivan Applauds Neopeutics' Commitment to Accelerating the Delivery of New Nature-Based Pharmaceuticals and Therapeutics 3Frost & Sullivan Applauds Neopeutics' Commitment to Accelerating the Delivery of New Nature-Based Pharmaceuticals and Therapeutics 4Frost & Sullivan Applauds Neopeutics' Commitment to Accelerating the Delivery of New Nature-Based Pharmaceuticals and Therapeutics 5
Cushing bayonet....
Straight, blunt tips....
Angled, pointed, with attached cable for Valleylab and other brands generators....
Autoclavable reusable pencil for Aaron 800 & 1200 - comes with generator or 1/box....
Medicine Products: